已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Endoscopic thyroidectomy through anterior chest and breast approach for papillary thyroid microcarcinoma

医学 甲状腺切除术 外科 甲状腺 皮下气肿 内科学 并发症
作者
Ping Wang,Zhiyu Li,Shuo Xu
出处
期刊:Chinese journal of surgery 卷期号:46 (19): 1480-1482 被引量:1
标识
DOI:10.3321/j.issn:0529-5815.2008.19.010
摘要

Objective To evaluate the operative feasibility and safety of endoscopic thyroidectomy through anterior chest and breast approach for the treatment of the patients with papillary thyroid microcarcinoma (PTMC). Methods Endoscopic thyroidectomy was attempted in 164 patients with thyroid diseases. For 28 cases, which were diagnosised as PTMC by frozen section intraopratively, lobotomy plus central compartment dissection and contralateral subtotal lobotomy was achieved completely by endoscopic thyroidectomy. There were 27 females and 1 male, and their average age was 35.2 years old. Twelve and sixteen cases were diagnosed preoperatively as thyroid microcarcinomas and benign tumors, respectively. Results The operation time of the 28 cases was (115±43) min.The maximum diameter of PTMC was0.2 to 1.0 cm with a mean of 0.56 cm. 17.9% (5/28) of the PTMC patients had transient vocal cord palsy and restored after 1 to 2 months postoperatively. There were no complications such as subcutaneous emphysema and postoperative bleeding and postoperative hypocalcaemia 46. 4% (13/28) had node involvement of the central compartment. Postoperative ultrasonography and scintigraphy showed no evidence of recurrence or residual thyroid tissue in the thyroid bed where lobotomy was performed. Conclusions The endoscopic thyroidectomy through anterior chest and breast approach is a choice of the surgical treatment for selected cases of PTMC. Key words: Thyroid neoplasms; Video-assisted surgery; Thyroidectomy

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐应助三石SUN采纳,获得10
刚刚
刚刚
地球翻转完成签到 ,获得积分10
2秒前
3秒前
铀氪锂锂完成签到,获得积分20
3秒前
一切皆有利于我完成签到 ,获得积分10
3秒前
SciGPT应助科研通管家采纳,获得10
4秒前
慕青应助科研通管家采纳,获得10
4秒前
英姑应助科研通管家采纳,获得10
4秒前
李健应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
彭于晏应助科研通管家采纳,获得10
5秒前
枫树狐狸完成签到,获得积分10
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
顺利萃发布了新的文献求助10
5秒前
今后应助科研通管家采纳,获得10
6秒前
别梦寒发布了新的文献求助10
6秒前
科研通AI2S应助科研通管家采纳,获得10
6秒前
6秒前
完美世界应助科研通管家采纳,获得10
6秒前
Zach完成签到,获得积分10
6秒前
海山应助科研通管家采纳,获得10
6秒前
乐乐应助科研通管家采纳,获得10
7秒前
123发布了新的文献求助10
8秒前
10秒前
朴实乐天完成签到,获得积分10
10秒前
等日落关注了科研通微信公众号
10秒前
不解释发布了新的文献求助10
11秒前
科研狗发布了新的文献求助10
11秒前
11秒前
11秒前
老实人发布了新的文献求助10
12秒前
13秒前
13秒前
完美世界应助顺利萃采纳,获得10
14秒前
年轻云朵哈完成签到,获得积分10
15秒前
道友且慢发布了新的文献求助20
15秒前
star发布了新的文献求助10
16秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6943815
求助须知:如何正确求助?哪些是违规求助? 8629338
关于积分的说明 18304845
捐赠科研通 6378618
什么是DOI,文献DOI怎么找? 3079068
关于科研通互助平台的介绍 2119722
邀请新用户注册赠送积分活动 2056006